Patient-Reported Outcomes for Tofacitinib With and Without Methotrexate, or Adalimumab With Methotrexate, in Rheumatoid Arthritis: A Phase IIIB/IV Trial
RMD Open - United Kingdom
doi 10.1136/rmdopen-2019-001040
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2019
Authors
Publisher
BMJ